Literature DB >> 15541061

Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Jane N Kogan1, Michael W Otto, Mark S Bauer, Ellen B Dennehy, David J Miklowitz, Hong-Wei Zhang, Terence Ketter, Matthew V Rudorfer, Stephen R Wisniewski, Michael E Thase, Joseph Calabrese, Gary S Sachs.   

Abstract

OBJECTIVES: Bipolar disorder is a severe, recurrent, and often highly impairing psychiatric disorder. The Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) is a large-scale multicenter study funded by the National Institute of Mental Health (NIMH) to examine the longitudinal course of the disorder and the effectiveness of current treatments. The current report provides a context for interpreting studies resulting from STEP-BD by summarizing the baseline demographic and diagnostic characteristics of the first 1000 enrolled.
METHODS: The majority of the sample met DSM-IV criteria for bipolar I disorder (71%). Mean age of patients was 40.6 (+/-12.7) years and mean duration of bipolar illness was 23.1 (+/-12.9) years. Among the first 1000 subjects enrolled, 58.6% are females and 92.6% Caucasian. This report compares the STEP-BD sample with other large cohorts of bipolar patients (treatment and community samples).
RESULTS: Compared with US population and community studies, the first 1000 STEP-BD patients were less racially diverse, more educated, had lower income, and a higher unemployment rate. Results are discussed in terms of the contributions of STEP-BD (and other large-scale treatment studies) in understanding the nature, treatments, and outcomes of bipolar disorder for patients seeking care at academic treatment centers.
CONCLUSIONS: The current report provides a context for interpreting future studies resulting from STEP-BD. The comparison of demographic and clinical characteristics between the samples across clinic-based studies suggests broad similarities despite the substantial differences in geography, payer mix, and clinical entry point. Blackwell Munksgaard, 2004

Entities:  

Mesh:

Year:  2004        PMID: 15541061     DOI: 10.1111/j.1399-5618.2004.00158.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  30 in total

1.  Disability and self-management practices of people with bipolar disorder: a web-based survey.

Authors:  Colin A Depp; John L Stricker; David Zagorsky; Lisa C Goodale; Lisa T Eyler; Thomas L Patterson; Barry D Lebowitz; Dilip V Jeste
Journal:  Community Ment Health J       Date:  2008-12-06

2.  Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study.

Authors:  A Slyepchenko; B N Frey; B Lafer; A A Nierenberg; G S Sachs; R S Dias
Journal:  Acta Psychiatr Scand       Date:  2017-08-28       Impact factor: 6.392

3.  Factors associated with functional recovery in bipolar disorder patients.

Authors:  Aliza P Wingo; Ross J Baldessarini; Paul E Holtzheimer; Philip D Harvey
Journal:  Bipolar Disord       Date:  2010-05       Impact factor: 6.744

4.  Cigarette smoking is associated with suicidality in bipolar disorder.

Authors:  Michael J Ostacher; Richard T Lebeau; Roy H Perlis; Andrew A Nierenberg; Hannah G Lund; Samantha J Moshier; Gary S Sachs; Naomi M Simon
Journal:  Bipolar Disord       Date:  2009-11       Impact factor: 6.744

5.  Suicidal ideation and depressive symptoms among bipolar patients as predictors of the health and well-being of caregivers.

Authors:  Cheryl A Chessick; Deborah A Perlick; David J Miklowitz; L Miriam Dickinson; Michael H Allen; Chad D Morris; Jodi M Gonzalez; Lauren B Marangell; Victoria Cosgrove; Michael Ostacher
Journal:  Bipolar Disord       Date:  2009-12       Impact factor: 6.744

6.  Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD.

Authors:  Eleonore Rydén; Christian Johansson; Kaj Blennow; Mikael Landén
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

7.  RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms.

Authors:  Thilo Deckersbach; Andrew A Nierenberg; Ronald Kessler; Hannah G Lund; Rebecca M Ametrano; Gary Sachs; Scott L Rauch; Darin Dougherty
Journal:  CNS Neurosci Ther       Date:  2010-10       Impact factor: 5.243

8.  Frequency of subsyndromal symptoms and employment status in patients with bipolar disorder.

Authors:  Michael Bauer; Tasha Glenn; Paul Grof; Natalie L Rasgon; Wendy Marsh; Kemal Sagduyu; Martin Alda; Ute Lewitzka; Johanna Sasse; Eliza Kozuch-Krolik; Peter C Whybrow
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-13       Impact factor: 4.328

9.  Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls.

Authors:  Margaret F Reynolds-May; Heather A Kenna; Wendy Marsh; Pascale G Stemmle; Po Wang; Terence A Ketter; Natalie L Rasgon
Journal:  Bipolar Disord       Date:  2013-11-22       Impact factor: 6.744

10.  Risperidone in the treatment of bipolar mania.

Authors:  Martha Sajatovic; Madhusoodanan Subramoniam; Matthew A Fuller
Journal:  Neuropsychiatr Dis Treat       Date:  2006-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.